ライフサイエンスコーパス: lung capacity

1 l bilirubin, balding, hemoglobin levels, and lung capacity.

2 with impaired muscle function, fitness, and lung capacity.

3 functional residual capacity (FRC) and total lung capacity.

4 flation was defined as residual volume/total lung capacity.

5 common in an ageing population, that reduce lung capacity.

6 d had a higher percentage of predicted total lung capacity.

7 expiratory volume in 1 second, and diffusing lung capacity.

8 n antibody, anti-RNP antibody, and decreased lung capacity.

9 fants from lung volumes initiated near total lung capacity.

10 ty (FVC) (P <.01) but not with FVC and total lung capacity.

11 piration thickness of the diaphragm at total lung capacity (0.386 +/- 0.144 cm vs. 0.439 +/- 0.134 cm

12 rmalities were associated with reduced total lung capacity (-0.444 liters; 95% confidence interval [C

13 es in residual volume as compared with total lung capacity (16 percent vs. 6 percent), but the decrea

14 and it reduced lung volumes (change in total lung capacity -16%; change in residual volume -55%) in a

15 consisted of two 30-sec inflations to total lung capacity (30 cm H(2)O) 1 min apart.

16 Hb-SS were characterized by decreased total lung capacities (70.2 +/- 14.7% predicted) and DLCO (64.

17 8% predicted (normal range, 80%-120%); total lung capacity, 72% predicted (normal range, 80%-120%); f

18 el displayed hyperinflation (change in total lung capacity +8%; change in residual volume +66%), redu

19 ); and the ratio of residual volume to total lung capacity, a measure of thoracic gas trapping, decre

20 A, complement, and carbon monoxide diffusion lung capacity adjusted for hemoglobin.

21 a would interact to cause increases in total lung capacity, airspace enlargement, and pulmonary infla

22 CT scans--were associated with reduced total lung capacity and a lesser amount of emphysema.

23 Total lung capacity and closing volume were defined by oxygena

24 lated immunity were associated with impaired lung capacity and diffusion, suggesting a postinjury pro

25 nd 3 years (28 patients; p=0.004), but total lung capacity and DLCO were not improved significantly a

26 canner, with spirometric monitoring at total lung capacity and during forced exhalation, with 40 mAs,

27 scanner with spirometric monitoring at total lung capacity and during forced exhalation.

28 of interstitial lung abnormalities on total lung capacity and emphysema was dependent on COPD status

29 abnormalities and HRCT measurements of total lung capacity and emphysema.

30 ith asthma underwent breath-hold CT at total lung capacity and functional residual capacity.

31 biome were associated with worse measures of lung capacity and gas diffusion.

32 y and full-lung CT-derived measures of total lung capacity and high attenuation area (HAA), and inter

33 terstitial disease and air-trapping in total lung capacity and residual volume images, respectively.

34 aging protocols for lung assessment at total lung capacity and residual volume.

35 , proton signal difference between TLC total lung capacity and RV residual volume correlated positive

36 ormalities are associated with reduced total lung capacity and the extent of emphysema is not known.

37 lung volumes (FVC, vital capacity, and total lung capacity) and lesser flows (FEV1 and forced expirat

38 tween 38.6 (39.8)% and 62.8 (31.1)% of total lung capacity, and 28 (36.3)% and 41.3 (38.7)% of pressu

39 xpiratory volume in 1 second, 116% for total lung capacity, and 60% for diffusing capacity of carbon

40 rea, airway wall area and thickness at total lung capacity, and air trapping at functional residual c

41 d significantly increased lung volume, total lung capacity, and alveolarization compared to wild type

42 4 significantly increased lung volume, total lung capacity, and alveolarization, while VEGF120 did no

43 nificantly decreased FEV(1), increased total lung capacity, and donor organ with lower pO(2) when ven

44 ty, reduced lung elasticity, increased total lung capacity, and dysregulated respiration.

45 ion lung capacity for carbon monoxide, total lung capacity, and forced vital capacity (rho = -0.76, -

46 ion lung capacity for carbon monoxide, total lung capacity, and forced vital capacity were rho = -0.6

47 its, autoimmunity, chronotype, bone density, lung capacity, and menopause age.

48 tissue damping, inspiratory capacity, total lung capacity, and others, were significantly and simila

49 0.60, P = .0008), and residual volume/total lung capacity (beta = -0.26, P = .02) were significant v

50 oxygen metabolism in an animal model with a lung capacity comparable to the human with minimal utili

51 individual lungs after LVRS, CT-derived mean lung capacity decreased 13% and residual volume 20% (p <

52 rs of smoking, current smoking status, total lung capacity, display field of view, and scanner type.

53 Predicted total lung capacity equations, or more simply, donor and recip

54 Females had diminished lung capacity, fewer mature alveoli, and medial hypertro

55 the proportion of patients with a diffusing lung capacity for carbon monoxide (Dlco) less than 80% o

56 ing: pulmonary function tests with diffusing lung capacity for carbon monoxide (DLCO); post-traumatic

57 ragmentation of the rhythm and the diffusing lung capacity for carbon monoxide (rho = -0.35) were obs

58 whole CT scan, correlated with the diffusion lung capacity for carbon monoxide, total lung capacity,

59 he disease extents correlated with diffusion lung capacity for carbon monoxide, total lung capacity,

60 (PFTs) included forced vital capacity, total lung capacity, forced expiratory volume in 1 second, and

61 ation were associated with a decreased total lung capacity, forced vital capacity, and diffusing capa

62 piratory pressure after deflation from total lung capacity, further demonstrating the effects of volu

63 Twelve-month changes in dyspnea score, total lung capacity, FVC, partial pressure of arterial oxygen,

64 We also collected lung capacity, grip strength, a series of balance tests,

65 predicted, significant hyperinflation (total lung capacity >100% and residual volume >150%), a restri

66 ed respiratory distress revealed compromised lung capacity in animals of both age groups at peak dise

67 e potential of PPARgamma agonists to restore lung capacity in emphysematous patients.

68 de (DLCO) is 45% of predicted, and his total lung capacity is 40% of predicted.

69 Decreased lung capacity is common and life-threatening across many

70 lts from rat experiments indicate that total lung capacity is increased when PEG is first added to th

71 ysmography tidal volume) compared with total lung capacity levels.

72 ly to have a restrictive lung deficit (total lung capacity <80% of the predicted value; odds ratio, 2

73 with asthma, a deep inhalation (DI) to total lung capacity may lead to bronchoconstriction.

74 rameters were significantly lower than total lung capacity, occurring at volumes between 38.6 (39.8)%

75 tion (ratio of residual volume [RV] to total lung capacity of >/=0.65).

76 reduction in mean (SD) residual volume/total lung capacity of -12% (12%) and an increase in FEV1 of 2

77 g volume was 4.0 L, with PFT showing a total lung capacity of 6.2 L, residual lung volume of 2.1 L, a

78 , FEV1/forced vital capacity ratio, transfer lung capacity of carbon monoxide, and Pao2.

79 ntly reduced expiratory compliance and total lung capacity (p < .05 from normal).

80 36.3)% and 41.3 (38.7)% of pressure at total lung capacity (p < 0.05; Bonferroni post-test).

81 ty (P = .0017), FEV(1) (P = .037), and total lung capacity (P = .013) but not their lung carbon monox

82 entage predicted, total lung capacity, total lung capacity percentage predicted, DLCO, or DLCO percen

83 tance, and ratio of residual volume to total lung capacity postalbuterol predicted more than 75% of F

84 1), oxygen utilization (p=0.04), lower total lung capacity % predicted (p=0.05), higher residual volu

85 ecipient oversizing based on predicted total lung capacity (pTLC) is associated with a reduced risk o

86 flation measured as residual volume to total lung capacity ratio (P=0.009).

87 correlated with the residual volume-to-total lung capacity ratio (rho = 0.6, P < .001).

88 lung volume or residual lung volume to total lung capacity ratio, is associated with greater LV mass.

89 ced vital capacity and residual volume/total lung capacity ratios) and greater reversibility to beta-

90 s loops performed after deflation from total lung capacity remained close to the envelope deflation c

91 structural changes with an increase in total lung capacity, resulting in chronic hypoxemia, hypercapn

92 sed by the ratio of residual volume to total lung capacity (RV/ TLC) (r = 0.66, p < 0.05) and exhaled

93 predicted ratio of residual volume to total lung capacity (RV/TLC%) (r = -0.65, P <.001), and percen

94 as defined as either a residual volume/total lung capacity (RV/TLC) above the upper limit of normal (

95 Residual volume/total lung capacity (RV/TLC) ratio decreased at 6 months and r

96 ses is the ratio of residual volume to total lung capacity (RV/TLC).

97 nd tracheal index with residual volume/total lung capacity (RV/TLC).

98 the residual volume as a proportion of total lung capacity (RV:TLC) did not change in either group.

99 an men after accounting for height and total lung capacity (segmental lumen diameter, 8.05 mm +/- 0.1

100 orrelated most strongly with decreased total lung capacity (Spearman rank correlation coefficient [r(

101 inspiration, static recoil pressure at total lung capacity, static lung compliance, expiratory flow r

102 Six-month changes in dyspnea score, total lung capacity, thoracic gas volume, FVC, FEV1, diffusing

103 0.05), and decreasing residual volume/total lung capacity (TLC) (P = 0.02) and % predicted residual

104 quantification from chest CT scans at total lung capacity (TLC) alone (fSAD(TLC)).

105 mary endpoints were CT lung density at total lung capacity (TLC) and functional residual capacity (FR

106 CT images at total lung capacity (TLC) and residual volume (RV) of 541 form

107 (CXR) measurements to estimate actual total lung capacity (TLC) could account for disease-related lu

108 ilator FEV1, residual volume (RV), and total lung capacity (TLC) were determined at baseline and at 6

109 Forced vital capacity (FVC) and total lung capacity (TLC) were measured.

110 S/LABA treatment, residual volume (RV)/total lung capacity (TLC)% predicted was reduced compared to b

111 iour, present in the dependent 4 cm at total lung capacity (TLC), affects the dependent 11 cm at func

112 pirometric, Feno, residual volume (RV)/total lung capacity (TLC), AHR, and Scond values significantly

113 Pretransplant FEV(1), FVC, total lung capacity (TLC), diffusing capacity of carbon monoxi

114 ility, and accuracy of measurements of total lung capacity (TLC), FRC, and their ratio, we determined

115 ctions in Vc, despite a well-preserved total lung capacity (TLC).

116 c transpulmonary pressures obtained at total lung capacity (TLC); actual TLC %of predicted and flow;

117 th IL-10 and IFN-gamma and % predicted total lung capacity (%TLC).

118 al capacity [ FRC+1 L 1 L above FRC ], total lung capacity [ TLC total lung capacity ]) with breath h

119 ional residual capacity and -950 HU at total lung capacity [TLC]).

120 qCT images (maximal bronchodilation at total lung capacity [TLC], or inspiration, and functional resi

121 group (-1.51 g/L per year [SE 0.25] at total lung capacity [TLC]; -1.55 g/L per year [0.24] at TLC pl

122 d unit (HU)-based density changes from total lung capacity to functional residual capacity (DeltaHU);

123 ing during forced expiration from near total lung capacity to residual volume.

124 uotient of tidal volume (normalized to total lung capacity) to tidal change in Pdi (normalized to Pdi

125 d vital capacity percentage predicted, total lung capacity, total lung capacity percentage predicted,

126 d in each infant, after recruitment to total lung capacity, using stepwise airway pressure decrements

127 as excised and inflated three times to total lung capacity (volume at 30 cm H2O) and expiratory compl

128 tional adjusted percent difference for total lung capacity was -1.33% (95% CI: -4.29, 1.72) and for c

129 ond (FEV1), forced vital capacity, and total lung capacity were categorized based on age, gender, hei

130 the ratio between residual volume and total lung capacity were significantly different between the E

131 static lung expansion that approaches total lung capacity with its negative impact on venous return.

132 above FRC ], total lung capacity [ TLC total lung capacity ]) with breath holds of 10-11 seconds, by